17-HYDROXYPROGESTERONE (17-OHP) - ANVISA Registration 10300390463

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10300390463 and manufactured by DIAGNOSTICS BIOCHEM CANADA INC. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAMETRA SRL, DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.